Search Results

1. Prescription Medications to Treat Overweight & Obesity

   /health-information/weight-management/prescription-medications-treat-overweight-obesity

   management medications for children ages 12 and older: orlistat (Xenical),2 liraglutide (Saxenda),3 phentermine-topiramate (Qsymia),4 and semaglutide (Wegovy...

2. What’s New in Medications for Weight Management for People with Diabetes

   /health-information/professionals/diabetes-discoveries-practice/new-in-medications-for-weight-management

   The diabetes medication semaglutide was recently approved to treat obesity, and other potentially effective obesity medications are in the pipeline...

3. Clinical Trials | Liver & Energy Metabolism Section

   /research-funding/at-niddk/labs-branches/liver-diseases-branch/liver-energy-metabolism-section/clinical-trials

   Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES) Background: In non-alcoholic...

4. Clinical Trials | Clinical Research Section

   /research-funding/at-niddk/labs-branches/liver-diseases-branch/clinical-research-section/clinical-trials

   the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES) Background: In non-alcoholic fatty liver disease (NAFLD), fat accumulates...

5. Making New Connections to Address the Silent Epidemic of Nonalcoholic Fatty Liver Disease

   /news/archive/2024/making-new-connections-address-silent-epidemic-nonalcoholic-fatty-liver-disease

   based drugs approved by the FDA for treating type 2 diabetes and obesity, such as semaglutide. These drugs work through a protein called the glucagon-like...

6. DDP Blog: Best of 2022

   /health-information/professionals/diabetes-discoveries-practice/best-ddp-blog-2022

   discusses the critical need for effective ways to treat and manage weight for people with diabetes. She also describes semaglutide and other new medications...

7. News Around NIDDK, Spring 2024 - Director's Update

   /about-niddk/meet-director/directors-update/2024-spring/news-around-niddk

   is beginning to be met. In 2021 the FDA approved Wegovy (semaglutide) for chronic weight management in adults with obesity or overweight with at least one weight...

8. What’s New in the 2024 ADA Standards of Care?

   /health-information/professionals/diabetes-discoveries-practice/ada-2024-standards-of-care

   semaglutide) or dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 receptor agonists (tirzepatide) to help achieve weight management...

9. 2024 Annual Mid-Atlantic Diabetes and Obesity Research Symposium

   /news/meetings-workshops/2024/mid-atlantic-diabetes-2024

   15 p.m. Coffee and Posters 3:15 p.m. – 3:30 p.m. Short Talk— Investigating the Intracellular Signaling Mechanism of Semaglutide...

10. The ADA’s 2022 Standards of Medical Care in Diabetes Update

    /health-information/professionals/diabetes-discoveries-practice/ada-2022-standards-of-medical-care-in-diabetes-update

    approved by the FDA for managing obesity, such as an oral hydrogel and semaglutide. Encouraging vaccines Not surprisingly, the new Standards of Care offers...